Skip to main content
OpenTrials
Completed

NCT Number: NCT02645240

Predictive Factors of Intestinal Infraction in Acute Mesenteric Ischemia

The study aims to identify several factors that can accurately predict the incident of intestinal infraction in patients with mesenteric vascular occlusion or ischemia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Mansoura university hospital

Al Mansurah, Dakahlia Governorate, Egypt

About this study

The study aims to identify several clinical, laboratory, and radiologic factors that can accurately predict the occurrence of intestinal infraction in patients with mesenteric vascular occlusion or ischemia in order to prevent unnecessary surgical intervention in patients with just intestinal ischemia and to hasten intervention in patients with actual intestinal gangrene.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with acute mesenteric Ischemia

Exclusion criteria

  • Patients with other causes of acute abdomen other than mesenteric Ischemia

Treatment and study plan

Heparin injection

Drug

Intravenous heparin injection in patients with acute mesenteric ischemia and evaluating their response within 24 hours

Other names: Low molecular weight heparin injection

Primary outcomes

  1. Clinical improvement

    Time frame: 48 hours

    Number of patients with resolved abdominal symptoms and incidence of patients developing shock

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Predictive Factors of Intestinal Infraction in Patients With Acute Mesenteric Ischemia

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Jan 1, 2016
Registry last updated
Aug 29, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.